“…In terms of potential treatments, Klinger et al [ 31 ] found that drugs targeting the cyclin-dependent kinase 6 (CDK6) are important for treating patients with this disease. Müller et al [ 32 ] discovered that SYT4 was down-regulated after a SARS-CoV-2 infection; however, while the authors establish a link between this gene and beta-cell physiology or diabetes, other authors, such as Jiang et al [ 33 ], discovered a link between this gene and immune cells.…”